Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin

Background Obesity is a serious disease that is associated with an increased risk of diabetes, hypertension, heart disease, stroke, and cancer, among other diseases. The United States Centers for Disease Control and Prevention (CDC) estimates a 20% obesity rate in the 50 states, with 12 states having rates of over 30%. Currently, the body mass index (BMI) is most commonly used to determine adiposity. However, BMI presents as an inaccurate obesity classification method that underestimates the epidemic and contributes to failed treatment. In this study, we examine the effectiveness of precise biomarkers and duel-energy x-ray absorptiometry (DXA) to help diagnose and treat obesity. Methodology/Principal Findings A cross-sectional study of adults with BMI, DXA, fasting leptin and insulin results were measured from 1998–2009. Of the participants, 63% were females, 37% were males, 75% white, with a mean age = 51.4 (SD = 14.2). Mean BMI was 27.3 (SD = 5.9) and mean percent body fat was 31.3% (SD = 9.3). BMI characterized 26% of the subjects as obese, while DXA indicated that 64% of them were obese. 39% of the subjects were classified as non-obese by BMI, but were found to be obese by DXA. BMI misclassified 25% men and 48% women. Meanwhile, a strong relationship was demonstrated between increased leptin and increased body fat. Conclusions/Significance Our results demonstrate the prevalence of false-negative BMIs, increased misclassifications in women of advancing age, and the reliability of gender-specific revised BMI cutoffs. BMI underestimates obesity prevalence, especially in women with high leptin levels (>30 ng/mL). Clinicians can use leptin-revised levels to enhance the accuracy of BMI estimates of percentage body fat when DXA is unavailable.

[1]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[2]  Haomiao Jia,et al.  Trends in quality-adjusted life-years lost contributed by smoking and obesity. , 2010, American journal of preventive medicine.

[3]  Gary R. Hunter,et al.  Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density , 2005, Osteoporosis International.

[4]  P. B. Eveleth,et al.  Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .

[5]  C. Mantzoros,et al.  Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications , 2010, Annals of Internal Medicine.

[6]  Tamara B Harris,et al.  Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. , 2009, The American journal of clinical nutrition.

[7]  F. Contaldo,et al.  High Leptin/Adiponectin Ratio and Serum Triglycerides Are Associated With an “At‐Risk” Phenotype in Young Severely Obese Patients , 2011, Obesity.

[8]  G. Frühbeck,et al.  Body Adiposity and Type 2 Diabetes: Increased Risk With a High Body Fat Percentage Even Having a Normal BMI , 2011, Obesity.

[9]  M. Sjöström,et al.  Neuromuscular training and the risk of leg injuries in female floorball players: cluster randomised controlled study , 2008, BMJ : British Medical Journal.

[10]  M. Karadağ,et al.  Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity , 2010, Annals of thoracic medicine.

[11]  V. Montori,et al.  Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis , 2010, International Journal of Obesity.

[12]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[13]  Mahbubur Rahman,et al.  Accuracy of Current Body Mass Index Obesity Classification for White, Black, and Hispanic Reproductive-Age Women , 2010, Obstetrics and gynecology.

[14]  H. Cai,et al.  Induction of leptin resistance through direct interaction of C-reactive protein with leptin , 2006, Nature Medicine.

[15]  M. Reilly,et al.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. , 2008, Journal of the American College of Cardiology.

[16]  M. Di Monaco,et al.  Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. , 2011, Archives of gerontology and geriatrics.

[17]  R N Pierson,et al.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.

[18]  K. Flegal.  Commentary: the quest for weight standards. , 2010, International journal of epidemiology.

[19]  P. Zimmet,et al.  Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study , 1996, BMJ.

[20]  L. Ferrucci,et al.  Sarcopenic obesity: definition, cause and consequences , 2008, Current opinion in clinical nutrition and metabolic care.

[21]  M. Quon,et al.  Leptin and Cardiovascular Disease: Response to Therapeutic Interventions , 2008, Circulation.

[22]  D. Sellen,et al.  Genetics of Criminal and Antisocial Behaviour. Ciba Foundation Symposium 194. Pp. 283. Edited by G. R. Bock & J. A. Goode. (Wiley, Chichester, 1996.) £50.00. , 1998, Journal of Biosocial Science.

[23]  V. Somers,et al.  Accuracy of body mass index in diagnosing obesity in the adult general population , 2008, International Journal of Obesity.

[24]  S. Malnick,et al.  The medical complications of obesity. , 2006, QJM : monthly journal of the Association of Physicians.

[25]  J. Martínez,et al.  Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. , 2010, The Journal of clinical endocrinology and metabolism.

[26]  F. Galvano,et al.  Normal-weight obese syndrome: early inflammation? , 2007, The American journal of clinical nutrition.

[27]  A. R. Frisancho.  Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.

[28]  W. Gulliver,et al.  Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[29]  R. Shephard.  Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .

[30]  Tony Reiman,et al.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. , 2008, The Lancet. Oncology.

[31]  G. Parati,et al.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. , 2010, European heart journal.

[32]  Mark Woodward,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[33]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[34]  O. Franco,et al.  Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study , 2009, BMJ : British Medical Journal.

[35]  Vladimir Vuksan,et al.  Defining Obesity Cut Points in a Multiethnic Population , 2007, Circulation.

[36]  D. DeMets,et al.  Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.

[37]  L. Houtkooper,et al.  Assessing the validity of body mass index standards in early postmenopausal women. , 2002, Obesity research.

[38]  C. Mantzoros.  The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence , 1999, Annals of Internal Medicine.

[39]  Donna Spiegelman,et al.  American Journal of Epidemiology Practice of Epidemiology Comparison of Dual-energy X-ray Absorptiometric and Anthropometric Measures of Adiposity in Relation to Adiposity-related Biologic Factors , 2022 .

[40]  J. Margareto,et al.  Role of baseline leptin and ghrelin levels on body weight and fat mass changes after an energy-restricted diet intervention in obese women: effects on energy metabolism. , 2011, The Journal of clinical endocrinology and metabolism.